Search Results

Filter
  • 1-10 of  13,534 results for ""Gemcitabine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Role of Dicer Phosphorylation in Gemcitabine Resistance of Pancreatic Cancer.

  • Authors : Chiu CF; Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University, Taipei 110, Taiwan.; Division of General Surgery, Shuang Ho Hospital, Taipei Medical University, Taipei 110, Taiwan.

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Nov 02; Vol. 25 (21). Date of Electronic Publication: 2024 Nov 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

A Tumor Homing Peptide-Linked Arsenic Compound Inhibits Pancreatic Cancer Growth and Enhances the Inhibitory Effect of Gemcitabine.

  • Authors : He H; Department of Surgery, University of Melbourne, Studley Road, Heidelberg, VIC 3084, Australia.; Dumesny C

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 22; Vol. 25 (21). Date of Electronic Publication: 2024 Oct 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Tumor-Colonizing E. coli Expressing Both Collagenase and Hyaluronidase Enhances Therapeutic Efficacy of Gemcitabine in Pancreatic Cancer Models.

  • Authors : Avsharian LC; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.; Irell and Manella Graduate School of Biological Sciences, City of Hope, Duarte, CA 91010, USA.

Subjects: Hyaluronoglucosaminidase*/Hyaluronoglucosaminidase*/Hyaluronoglucosaminidase*/metabolism ; Hyaluronoglucosaminidase*/Hyaluronoglucosaminidase*/Hyaluronoglucosaminidase*/genetics ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives

  • Source: Biomolecules [Biomolecules] 2024 Nov 17; Vol. 14 (11). Date of Electronic Publication: 2024 Nov 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Synergistic Inhibition of Pancreatic Cancer Cell Growth and Migration by Gemcitabine and Withaferin A.

  • Authors : Szydlak R; Department of Bioinformatics and Telemedicine, Faculty of Medicine, Jagiellonian University Medical College, Medyczna 7, 30-688 Krakow, Poland.

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: Biomolecules [Biomolecules] 2024 Sep 19; Vol. 14 (9). Date of Electronic Publication: 2024 Sep 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Tissue- and Temporal-Dependent Dynamics of Myeloablation in Response to Gemcitabine Chemotherapy.

  • Authors : Kitelinger LE; Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA.; Thim EA

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: Cells [Cells] 2024 Aug 07; Vol. 13 (16). Date of Electronic Publication: 2024 Aug 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Growth Hormone Receptor Antagonist Markedly Improves Gemcitabine Response in a Mouse Xenograft Model of Human Pancreatic Cancer.

  • Authors : Basu R; Edison Biotechnology Institute, Ohio University, Athens, OH 45701, USA.; Diabetes Institute, Ohio University, Athens, OH 45701, USA.

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jul 06; Vol. 25 (13). Date of Electronic Publication: 2024 Jul 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Encapsulation of Gemcitabine on Porphyrin Aluminum Metal-Organic Framework by Mechano-Chemistry, Delayed Drug Release and Cytotoxicity to Pancreatic Cancer PANC-1 Cells.

  • Authors : Umar S; Department of Chemistry, Morgan State University, 1700 East Cold Spring Lane, Baltimore, MD 21251, USA.; Samokhvalov A

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/chemistry

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Jul 04; Vol. 29 (13). Date of Electronic Publication: 2024 Jul 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

The Crosstalk Analysis between mPSCs and Panc1 Cells Identifies CCN1 as a Positive Regulator of Gemcitabine Sensitivity in Pancreatic Cancer Cells.

  • Authors : Gündel B; Pancreas Cancer Research Lab, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, SE 141 86 Huddinge, Sweden.; Liu X

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology ; Cysteine-Rich Protein 61*/Cysteine-Rich Protein 61*/Cysteine-Rich Protein 61*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 29; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Elucidation of the Gemcitabine Transporters of Escherichia coli K-12 and Gamma-Proteobacteria Linked to Gemcitabine-Related Chemoresistance.

  • Authors : Iosifidou N; Laboratory of Biological Chemistry, Department of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.; Anagnostopoulou E

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 27; Vol. 25 (13). Date of Electronic Publication: 2024 Jun 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Development and Validation of a Simple and Reliable HPLC-UV Method for Determining Gemcitabine Levels: Application in Pharmacokinetic Analysis.

  • Authors : Lafazanis K; Department of Pharmacology, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece.; Begas E

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/pharmacokinetics ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/blood

  • Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 May 25; Vol. 60 (6). Date of Electronic Publication: 2024 May 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  13,534 results for ""Gemcitabine""